Suchergebnisse - "Bereswill, Mareike"

PubPharm (13)

1

Addressing statistical issues when leveraging external control data in pediatric clinical trials using Bayesian dynamic borrowing

enthalten in: Journal of biopharmaceutical statistics | 2023

von Spanakis, E. | Kron, M. | Bereswill, M. | +1

2

Bridging Fixed Dose to Body Weight-based Regimen of Adalimumab in Paediatric Ulcerative Colitis Using a Pharmacometric Modelling Approach : Case Study with the Phase 3 ENVISION I Trial

enthalten in: Journal of Crohn's & colitis | 2022

von Stodtmann, S. | Chen, M. | Siovitz, L. | +6

3

Observational data from the adalimumab post-marketing PYRAMID registry of patients with Crohn's disease who became pregnant : A post hoc analysis

enthalten in: United European gastroenterology journal | 2022

von Hart, A. | D'Haens, G. | Bereswill, M. | +9

4

Observational data from the adalimumab post‐marketing PYRAMID registry of patients with Crohn's disease who became pregnant : A post hoc analysis

enthalten in: United European Gastroenterology Journal | 2022

von Hart, A. | D’Haens, G. | Bereswill, M. | +9

5

Efficacy and safety of adalimumab in paediatric patients with moderate-to-severe ulcerative colitis (ENVISION I) : a randomised, controlled, phase 3 study

enthalten in: The lancet. Gastroenterology & hepatology | 2021

von Croft, N. | Faubion, W. | Kugathasan, S. | +10

CommentIn: Lancet Gastroenterol Hepatol. 2021 Aug;6(8):598-599. - PMID 34153230

6

Safety and Effectiveness of Adalimumab in Patients With Polyarticular Course of Juvenile Idiopathic Arthritis : STRIVE Registry Seven-Year Interim Results

enthalten in: Arthritis care & research | 2020

von Brunner, H. | Nanda, K. | Toth, M. | +22

7

Safety and Effectiveness of Adalimumab in Patients With Polyarticular Course of Juvenile Idiopathic Arthritis : STRIVE Registry Seven‐Year Interim Results

enthalten in: Arthritis Care & Research | 2020

von Brunner, H. | Nanda, K. | Toth, M. | +21

8

Adalimumab Effectiveness Up to Six Years in Adalimumab-naïve Patients with Crohn's Disease : Results of the PYRAMID Registry

enthalten in: Inflammatory bowel diseases | 2019

von Loftus, E. | Reinisch, W. | Panaccione, R. | +8

9

Lymphoma Risk and Overall Safety Profile of Adalimumab in Patients With Crohn's Disease With up to 6 Years of Follow-Up in the Pyramid Registry

enthalten in: The American journal of gastroenterology | 2018

von DʼHaens, G. | Reinisch, W. | Panaccione, R. | +10

10

Effect of Adalimumab on Clinical Outcomes and Health-related Quality of Life Among Patients With Ulcerative Colitis in a Clinical Practice Setting : Results From InspirADA

enthalten in: Journal of Crohn's & colitis | 2017

von Travis, S. | Feagan, B. | Peyrin-Biroulet, L. | +12